DNA SEQ

United States
San Diego, California, United States, 92037

Company profile

DNA SEQ company profile

DNA SEQ provides reports that match the patient's genomic profile to targeted therapies using unique crystallography based filtering methodology. Unique technology alliance that has developed a machine learning algorithm based on structural genomics leveraging crystallography and our proprietary crystal structures library, to match genomics of cancer patients with available targeted oncology drugs. Our predictive personalized medicine approach helps physicians make treatment decisions for cancer patients by identifying the molecular growth drivers of the cancer, and matching them to relevant targeted therapeutic options. NGS of the entire exome verse just panels because each patient’s resistance is different. Research reports that help physicians make treatment decisions for cancer patients by identifying the molecular growth drivers of the cancer, and matching them to relevant targeted therapeutic options.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Revenue range
$0+
Founded
2013-05-24

Headquarters

Postal code
92037
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Seed
Funding rounds
1
Total equity funding
$1M
Last funding
Seed / $1M / 2013-05-24
Last equity funding
Seed / $1M
Founders
2
Articles
5

Founders and investors

Founders

David DoyleJanusz Sowadski